Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients von Robinson-Cohen, Cassianne, Newitt, Richard, Shen, Danny D, Rettie, Allan E, Kestenbaum, Bryan R, Himmelfarb, Jonathan, Yeung, Catherine K

Volltext

Clinical and toxicological relevance of CYP2C9: Drug-drug interactions and pharmacogenetics von RETTIE, Allan E, JONES, Jeffrey P

Volltext

Applying Multiplex Assays to Understand Variation in Pharmacogenes von Chiasson, Melissa, Dunham, Maitreya J., Rettie, Allan E., Fowler, Douglas M.

Volltext

Pharmacogenomics of 4-Hydroxycoumarin Anticoagulants von Au, Nicholas, Rettie, Allan E.

Volltext

Cytochrome P450 2C8: Substrates, Inhibitors, Pharmacogenetics, and Clinical Relevance von Totah, Rheem A., Rettie, Allan E.

Volltext

Improved methods for the detection of heme and protoporphyrin IX adducts and quantification of heme B from cytochrome P450 containing systems von Pelletier, Robert D, Rettie, Allan E, Kowalski, John P

Volltext

Expression and Characterization of CYP4V2 as a Fatty Acid ω-Hydroxylase von Nakano, Mariko, Kelly, Edward J., Rettie, Allan E.

Volltext

Sequential Metabolism and Bioactivation of the Hepatotoxin Benzbromarone: Formation of Glutathione Adducts From a Catechol Intermediate von McDonald, Matthew G, Rettie, Allan E

Volltext

Generation and characterization of a murine model of Bietti crystalline dystrophy von Lockhart, Catherine M, Nakano, Mariko, Rettie, Allan E, Kelly, Edward J

Volltext

Stable isotope applications in drug development and the elucidation of mechanisms of drug metabolism von Totah, Rheem A., Rettie, Allan E.

Volltext

Role of Biotransformation in Drug-Induced Toxicity: Influence of Intra- and Inter-Species Differences in Drug Metabolism von Baillie, Thomas A., Rettie, Allan E.

Volltext

Correction: Stable isotope applications in drug development and the elucidation of mechanisms of drug metabolism von Totah, Rheem A., Rettie, Allan E.

Volltext

Adapting regulatory drug‐drug interaction guidance to design clinical pharmacokinetic natural product‐drug interaction studies: A NaPDI Center recommended approach von Cox, Emily J., Rettie, Allan E., Unadkat, Jashvant D., Thummel, Kenneth E., McCune, Jeannine S., Paine, Mary F.

Volltext

CYP2C9 Genotype‐Dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R‐ and S‐Warfarin and Their Oxidative Metabolites von Flora, Darcy R., Rettie, Allan E., Brundage, Richard C., Tracy, Timothy S.

Volltext

A Physiological-Based Pharmacokinetic Model Embedded with a Target-Mediated Drug Disposition Mechanism Can Characterize Single-Dose Warfarin Pharmacokinetic Profiles in Subjects wi... von Cheng, Shen, Flora, Darcy R, Rettie, Allan E, Brundage, Richard C, Tracy, Timothy S

Volltext

CYP2C9 Amino Acid Residues Influencing Phenytoin Turnover and Metabolite Regio- and Stereochemistry von Mosher, Carrie M, Tai, Guoying, Rettie, Allan E

Volltext

Preface to Special Issue on 'Cytochrome P450 Variation in Pharmacogenomics' von Rettie, Allan E, Liggett, Stephen B

Volltext

Pharmacokinetic Modeling of Warfarin І - Model-based Analysis of Warfarin Enantiomers with a Target Mediated Drug Disposition Model Reveals CYP2C9 Genotype-dependent Drug-drug Inte... von Cheng, Shen, Flora, Darcy R, Rettie, Allan E, Brundage, Richard C, Tracy, Timothy S

Volltext

Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression von KOUKOURITAKI, Sevasti B, SIMPSON, Pippa, YEUNG, Catherine K, RETTIE, Allan E, HINES, Ronald N

Volltext

An analysis of the relative effects of VKORCI and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients von MECKLEY, Lisa M, WITTKOWSKY, Ann K, RIEDER, Mark J, RETTIE, Allan E, VEENSTRA, David L

Volltext